New Delhi, Apr 26 (IANS): The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech's Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E's Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Comment on this article
Dev, Mangalore
Tue, Apr 26 2022I've been warning parents about this since 1 year. Nobody protested when it was introduced for 18 years and later to14 years. Anyway its not compulsory and voluntary, better get together and form groups to get the vaccine mafia to keep off our kids for their greed.
DisAgree [1] Agree [4] Reply Report Abuse
Mangalurian, Mangaluru
Tue, Apr 26 2022Children in this age-group almost never suffer from comorbidities. So, their symptoms will be either zero or like a mild cold. Why vaccinate them?
DisAgree [2] Agree [8] Reply Report Abuse
real kujuma, kodial
Tue, Apr 26 2022time for vaccine companies to mint money and also for ruling political parties to amass wealth..let the show begin
DisAgree [1] Agree [4] Reply Report Abuse